NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service — Liqiang Xi (DIVISION OF BASIC SCIENCES - NCI)
The Molecular Diagnostics Section is currently the only CLIA and College of American Pathology approved clinical laboratory within the NCI certified for performing molecular oncology testing on pathol
| Project title | NCI COMPASS-Comprehensive Oncologic Molecular Pathology and Sequencing Service |
|---|---|
| Project number | 1ZIDBC011959-05 |
| PI name | Liqiang Xi |
| Institution | DIVISION OF BASIC SCIENCES - NCI |
| Funding mechanism | ZID |
| Agency | NCI |
| Award amount | $7.04M |
| Fiscal year | 2024 |
| Abstract | The Molecular Diagnostics Section is currently the only CLIA and College of American Pathology approved clinical laboratory within the NCI certified for performing molecular oncology testing on pathol |
| Key terms | <American><Assay><Bioassay><Biological Assay><CCR><Cancer Patient><Cancers><Cell Body><Cells><Certif |
$799/mo
Try GrantRadar →